Chris Springate

Dr. Chris Springate has over 25 years of experience as a leader in the development of medical devices, combination products and drugs at preclinical and early clinical stage medical device companies. He engaged in the development of several successful products including the Taxus® Stent with sales of greater than USD 1 billion annually; built leadership teams including corporate, scientific and clinical boards; co-led ARC in acquiring greater than USD 30 million of equity and licensing financing; and is an inventor of several patent families that protect ARC’s products. Dr. Springate served as a hospital and community pharmacist for 7 years. He holds BSc (Pharm) and PhD (Pharm) degrees and is a Registered Pharmacist.